Yes. Polycystic ovary syndrome (PCOS) and endometriosis can coexist, and studies that look for both in the same woman find them together more often than either condition alone would predict. The overlap is not rare or theoretical; it is a documented clinical pattern, and it matters because each disease can mask the other.

PCOS is a hormonal and metabolic disorder defined by irregular ovulation, excess androgen activity, and often insulin resistance. Endometriosis is an inflammatory disease in which tissue resembling the uterine lining grows outside the uterus. They arise from different mechanisms in different tissues, so nothing about having one prevents the other. The practical problem is that a diagnosis of PCOS often closes the investigation too early, while endometriosis hides behind symptoms everyone attributes to hormones.

Two diseases, two mechanisms

PCOS is primarily a signaling disorder of the hypothalamic-pituitary-ovarian axis. Elevated luteinizing hormone pulse frequency drives ovarian theca cells to produce more androgens. At the same time, insulin resistance raises insulin levels, and insulin amplifies androgen production while lowering hepatic production of sex hormone-binding globulin. The result is more free testosterone and disrupted follicle maturation, so ovulation becomes irregular or absent.

Endometriosis is primarily a disease of ectopic tissue and inflammation. Cells resembling endometrium implant outside the uterus, most often on the pelvic peritoneum and ovaries. These implants respond to estrogen, bleed cyclically, and provoke a local inflammatory response. That inflammation recruits macrophages, raises local cytokine levels, and generates adhesions and scar tissue. Pain comes from inflammation and nerve involvement, not from the size of the lesions.

The two processes can reinforce each other. Chronic inflammation from endometriosis can disturb ovarian function. Insulin resistance and the resulting hyperandrogenism in PCOS can alter the hormonal environment in which endometriotic implants grow. Neither causes the other in any established causal sense, but each can make the other more symptomatic.

Plain language: one condition is a hormone-signaling problem, the other is misplaced tissue causing inflammation, and the two can run in parallel.

How often they overlap, by the numbers

Exact prevalence is uncertain because diagnostic standards differ and because confirming endometriosis requires surgery in most cases. Still, the direction of the evidence is consistent.

PCOS affects roughly 8 to 13 percent of reproductive-age women depending on the diagnostic criteria used. Endometriosis is estimated at roughly 10 percent of reproductive-age women, though estimates range from 2 to 11 percent in population studies. Among women with endometriosis, studies have reported PCOS in roughly 10 to 25 percent in clinic-based samples. Among women with PCOS, endometriosis has been reported in roughly 5 to 20 percent, with wide variation by referral population. Roughly 30 to 50 percent of women with endometriosis experience infertility, and anovulatory infertility is a defining feature of PCOS. The average delay from first symptoms to surgical diagnosis of endometriosis is often cited as 7 to 10 years.

These ranges are broad because clinic-based samples inflate prevalence through referral bias. A woman referred to a fertility clinic is more likely to be worked up for both conditions than a woman seen in primary care. Treat the numbers as signals of a real overlap, not as precise population estimates.

The overlap also changes the fertility picture. PCOS reduces ovulation frequency, and endometriosis damages pelvic anatomy and egg quality. When both are present, infertility is not simply additive; the two mechanisms compound the delay to conception.

Why diagnosis fails in both directions

The core clinical problem is anchoring. Once a clinician finds one explanation for irregular cycles or pelvic pain, the search tends to stop.

If PCOS is diagnosed first, pelvic pain is often attributed to dysmenorrhea or to the hormonal irregularity itself. Endometriosis pain is frequently normalized as "bad periods," and the patient may be told that treating the PCOS will resolve the pain. It will not, because the two pain mechanisms are different.

If endometriosis is diagnosed first, irregular cycles and metabolic features may be attributed to the stress of chronic pain or to the hormonal treatments used for endometriosis. Those treatments, including combined oral contraceptives and progestins, can mask PCOS features by regulating bleeding artificially.

A counterintuitive detail: the ovarian cysts seen on ultrasound are not diagnostic of PCOS by themselves. A woman with endometriosis can have endometriomas, which are cysts formed by endometriotic tissue on the ovary. On imaging these can resemble the small follicles of PCOS, and clinicians sometimes mislabel them. An endometrioma typically has ground-glass contents and is usually larger and fewer in number than the 12 or more small peripheral follicles that define the polycystic ovarian morphology. Getting the imaging interpretation right changes the diagnosis.

Where the two conditions get confused

The table below contrasts features that are commonly conflated, especially when both conditions are present.

Feature PCOS Endometriosis
Primary mechanism Hormonal and metabolic dysregulation Ectopic endometrial-like tissue and inflammation
Typical cycle pattern Irregular or absent ovulation Often ovulatory, with cyclic pain
Pain pattern Not a defining feature Cyclic pelvic pain, dyspareunia, dyschezia
Imaging 12 or more small follicles per ovary (rotterdam threshold) Endometriomas, adhesions, deep infiltrating lesions
Definitive diagnosis Clinical criteria plus exclusion of other causes Surgical visualization, often with biopsy
Infertility mechanism Anovulation, metabolic effects Anatomic distortion, inflammation, egg quality
First-line management focus Metabolic and ovulatory Pain control and surgical or hormonal suppression

A woman can meet the criteria for both simultaneously. Meeting criteria for one does not exclude the other, and clinicians should evaluate symptoms that do not fit the established diagnosis rather than assume the diagnosis explains everything.

Red-flag warnings that should trigger a broader workup:

Pelvic pain that does not respond to hormonal therapy used for PCOS. Pain with intercourse or bowel movements that worsens cyclically. New or worsening pain despite regular cycles on hormonal contraception. Very heavy or prolonged bleeding with pain, particularly if bleeding pattern changes. Infertility that persists after ovulation is restored with treatment. A pelvic mass that does not fit the typical polycystic ovarian appearance on imaging.

The time course of diagnosis and treatment

The timeline matters because the two diagnoses usually emerge at different points in a woman's life, and delays accumulate.

Age and stage What typically happens
Adolescence (12 to 18) Irregular cycles attributed to normal puberty; PCOS criteria may not be applied until 2 to 3 years after menarche
Early adulthood (18 to 25) PCOS often diagnosed; pelvic pain normalized as severe dysmenorrhea
Mid to late twenties (25 to 32) Endometriosis suspicion rises, especially with infertility or worsening pain
Diagnostic surgery (variable) Laparoscopy confirms endometriosis; median delay of several years from symptom onset
Treatment phase Combined hormonal therapy may mask both conditions; ovulation induction needed for fertility
Post-diagnosis Both conditions managed in parallel, with attention to metabolic health and pain control

The key point is that the two conditions are usually diagnosed years apart, so a woman may carry one label for a long time before the second is recognized. The delay is not evidence that the second condition is absent.

Practical steps and thresholds

Concrete actions that change outcomes:

If you have a PCOS diagnosis and persistent pelvic pain, ask directly whether endometriosis has been considered. Bring a written pain and cycle log covering at least 3 months. Track the pattern of pain relative to your cycle. Cyclic pain that peaks with menstruation and with ovulation points toward endometriosis; constant pain suggests other causes or advanced disease. Request transvaginal ultrasound with attention to cyst morphology. Note whether cysts are small and peripheral, which suggests PCOS, or ground-glass and larger, which suggests endometrioma. If fertility treatment for PCOS is not working after 3 to 6 ovulatory cycles, raise the possibility of endometriosis before escalating doses. Ask about metabolic screening, including fasting glucose and lipids, because insulin resistance is common in PCOS and affects long-term risk. Seek a gynecologic specialist with experience in both conditions if your symptoms do not fit one diagnosis cleanly.

Thresholds to be aware of: PCOS diagnosis generally requires at least 2 of 3 criteria (irregular ovulation, clinical or biochemical hyperandrogenism, and polycystic ovarian morphology), with other causes excluded. The follicle threshold on ultrasound is typically 12 or more follicles per ovary using older criteria, with some guidelines using a higher threshold with newer imaging. Endometriosis has no blood test; diagnosis generally requires visualization, and surgical confirmation remains the reference standard even when imaging is suggestive.

Reconciling thresholds: a woman can meet PCOS criteria by having irregular cycles and elevated androgens without any cysts, and she can have endometriosis with completely regular cycles. The two diagnostic pathways do not intersect, so the presence of one does not lower the probability of the other.

Limitations and unknowns

The evidence base has real limits. Most studies of the overlap come from referral centers, so the true population prevalence is uncertain. Diagnostic criteria for PCOS have shifted over time, which makes older prevalence data hard to compare with current data. Endometriosis diagnosis still relies on surgery in many settings, so women without access to laparoscopy are underrepresented in the data.

The mechanisms linking the two conditions are plausible but not fully established. Shared genetic and inflammatory pathways have been proposed, but the research is early and the causal direction is unclear. No single test or biomarker identifies both conditions together.

What is clear is the clinical implication. A woman with one diagnosis and symptoms that do not fit should not accept the first explanation as final. The overlap is common enough, and the diagnostic delay is long enough, that a second look is warranted.